138 related articles for article (PubMed ID: 31924662)
1. Sleep disturbance in patients with cancer: a feasibility study of multimodal therapy.
Yennurajalingam S; Carmack C; Balachandran D; Eng C; Lim B; Delgado M; Guzman Gutierrez D; Raznahan M; Park M; Hess KR; Williams JL; Lu Z; Ochoa J; Bruera E
BMJ Support Palliat Care; 2021 Jun; 11(2):170-179. PubMed ID: 31924662
[TBL] [Abstract][Full Text] [Related]
2. Light-enhanced cognitive behavioural therapy for sleep and fatigue: study protocol for a randomised controlled trial during chemotherapy for breast cancer.
Bean HR; Stafford L; Little R; Diggens J; Ftanou M; Alexander M; Francis PA; Bei B; Wiley JF
Trials; 2020 Mar; 21(1):295. PubMed ID: 32216832
[TBL] [Abstract][Full Text] [Related]
3. Effect of a Multi-Layer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adults with ADHD: A Randomized, Double-Blind, Forced-Dose, Placebo-Controlled Trial Followed by a 6-month Open-Label Extension.
Weiss MD; Surman C; Khullar A; He E; Cataldo M; Donnelly G
CNS Drugs; 2021 Jun; 35(6):667-679. PubMed ID: 34057707
[TBL] [Abstract][Full Text] [Related]
4. Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial.
Bruera E; Yennurajalingam S; Palmer JL; Perez-Cruz PE; Frisbee-Hume S; Allo JA; Williams JL; Cohen MZ
J Clin Oncol; 2013 Jul; 31(19):2421-7. PubMed ID: 23690414
[TBL] [Abstract][Full Text] [Related]
5. Bright light treatment in elderly patients with nonseasonal major depressive disorder: a randomized placebo-controlled trial.
Lieverse R; Van Someren EJ; Nielen MM; Uitdehaag BM; Smit JH; Hoogendijk WJ
Arch Gen Psychiatry; 2011 Jan; 68(1):61-70. PubMed ID: 21199966
[TBL] [Abstract][Full Text] [Related]
6. Effects of Melatonin and Bright Light Treatment in Childhood Chronic Sleep Onset Insomnia With Late Melatonin Onset: A Randomized Controlled Study.
van Maanen A; Meijer AM; Smits MG; van der Heijden KB; Oort FJ
Sleep; 2017 Feb; 40(2):. PubMed ID: 28364493
[TBL] [Abstract][Full Text] [Related]
7. Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial.
Kerr CW; Drake J; Milch RA; Brazeau DA; Skretny JA; Brazeau GA; Donnelly JP
J Pain Symptom Manage; 2012 Jan; 43(1):68-77. PubMed ID: 22208450
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic effects and safety of bright light therapy combined with escitalopram oxalate on insomnia in patients with poststroke depression.
Xiao M; Feng L; Wang Q; Luan X; Chen S; He J
Int J Geriatr Psychiatry; 2021 Jan; 36(1):182-189. PubMed ID: 32830332
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
Wade AG; Ford I; Crawford G; McMahon AD; Nir T; Laudon M; Zisapel N
Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
[TBL] [Abstract][Full Text] [Related]
10. A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes.
Chen WY; Giobbie-Hurder A; Gantman K; Savoie J; Scheib R; Parker LM; Schernhammer ES
Breast Cancer Res Treat; 2014 Jun; 145(2):381-8. PubMed ID: 24718775
[TBL] [Abstract][Full Text] [Related]
11. Correcting delayed circadian phase with bright light therapy predicts improvement in ADHD symptoms: A pilot study.
Fargason RE; Fobian AD; Hablitz LM; Paul JR; White BA; Cropsey KL; Gamble KL
J Psychiatr Res; 2017 Aug; 91():105-110. PubMed ID: 28327443
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of melatonin for sleep disturbance in middle-aged primary insomnia: a double-blind, randomised clinical trial.
Xu H; Zhang C; Qian Y; Zou J; Li X; Liu Y; Zhu H; Meng L; Liu S; Zhang W; Yi H; Guan J; Chen Z; Yin S
Sleep Med; 2020 Dec; 76():113-119. PubMed ID: 33157425
[TBL] [Abstract][Full Text] [Related]
13. Effect of bright light therapy on cancer-related fatigue and related symptoms: A systematic review and meta-analysis of randomized controlled trials.
Lin LY; Tam KW; Huang TW
J Psychosom Res; 2023 Nov; 174():111501. PubMed ID: 37797569
[TBL] [Abstract][Full Text] [Related]
14. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N
BMC Med; 2010 Aug; 8():51. PubMed ID: 20712869
[TBL] [Abstract][Full Text] [Related]
15. Melatonin for treatment of sleeping disorders in children with attention deficit/hyperactivity disorder: a preliminary open label study.
Tjon Pian Gi CV; Broeren JPA; Starreveld JS; A Versteegh FG
Eur J Pediatr; 2003 Jul; 162(7-8):554-555. PubMed ID: 12783318
[No Abstract] [Full Text] [Related]
16. A double-blind randomized controlled trial to assess the effect of bright light therapy on depression in patients with Parkinson's disease.
Rutten S; Vriend C; Smit JH; Berendse HW; Hoogendoorn AW; van den Heuvel OA; van der Werf YD
BMC Psychiatry; 2016 Oct; 16(1):355. PubMed ID: 27769202
[TBL] [Abstract][Full Text] [Related]
17. Poorer sleep quality predicts melatonin response in patients with traumatic brain injury: findings from a randomized controlled trial.
Grima NA; Rajaratnam SMW; Mansfield D; McKenzie D; Ponsford JL
J Clin Sleep Med; 2021 Aug; 17(8):1545-1551. PubMed ID: 33704046
[TBL] [Abstract][Full Text] [Related]
18. Methylphenidate side effects in advanced cancer: a retrospective analysis.
Lasheen W; Walsh D; Mahmoud F; Davis MP; Rivera N; Khoshknabi DS
Am J Hosp Palliat Care; 2010 Feb; 27(1):16-23. PubMed ID: 19745210
[TBL] [Abstract][Full Text] [Related]
19. The use of MElatonin in children with neurodevelopmental disorders and impaired sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS).
Appleton RE; Jones AP; Gamble C; Williamson PR; Wiggs L; Montgomery P; Sutcliffe A; Barker C; Gringras P
Health Technol Assess; 2012; 16(40):i-239. PubMed ID: 23098680
[TBL] [Abstract][Full Text] [Related]
20. Sleep laboratory investigations on hypnotic properties of melatonin.
Waldhauser F; Saletu B; Trinchard-Lugan I
Psychopharmacology (Berl); 1990; 100(2):222-6. PubMed ID: 2305009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
